New types of measurements could help provide a more holistic view of the impact of hemophilia treatments.
People with cancer sometimes seek out unapproved investigational medicines. Dr. Hal Barron talks about the Expanded Access Program (EAP) and other compassionate use cases that make it possible.
Genentech neurologist Peter Chin looks at the past, present, and future of drug development for multiple sclerosis.
Tell us what you think about our company, products, or website.
The most exciting phrase to hear in science, the one that heralds new discoveries, is not "Eureka!" but "That’s funny…"